Beta Alethine in Treating Patients With Myeloma

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Multiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition

In brief

RATIONALE: Biological therapies such as beta alethine use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I/II trial to study the effectiveness of beta alethine in treating patients who have myeloma.

Key facts

Study ID

NCT00006466

Run by

LifeTime Pharmaceuticals

Starts

2000-08-01

Last updated by the study team

2013-12-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Emory Clinic — Atlanta, Georgia, United States
• Victory Over Cancer — Rockville, Maryland, United States
• St. Vincents Comprehensive Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.